News from paratek pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 07, 2004, 01:00 ET

Paratek Pharmaceuticals to Expand Malaria Program Under Two-Year NIH Phase II SBIR Grant

BOSTON, July 7 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced today the initiation of the next phase of the Company's program to...

May 03, 2004, 01:00 ET

Bayer and Paratek Pharmaceuticals Present New Data on First Antibiotic in New Class, Aminomethylcyclines (AMCs), at 14th Annual ECCMID

LEVERKUSEN, Germany and BOSTON, May 3 /PRNewswire-FirstCall/ -- Bayer AG, Bayer Pharmaceuticals Corporation (USA), and Paratek Pharmaceuticals,...

Mar 23, 2004, 00:00 ET

Paratek Pharmaceuticals to Present at Wells Fargo Securities Health Care Conference

NEW YORK, March 23 /PRNewswire/ -- Paratek Pharmaceuticals, Inc., a private Boston-based pharmaceuticals company that is engaged in the...

Feb 24, 2004, 00:00 ET

Paratek Pharmaceuticals and Medicines for Malaria Venture Collaborate To Discover Novel Antimalarial Compounds

BOSTON and GENEVA, Feb. 24 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. and Medicines for Malaria Venture (MMV), a non-profit foundation, have...

Dec 03, 2003, 00:00 ET

Paratek Issued U.S. Patents Covering Methods Of Preparing Substituted Tetracyclines

BOSTON, Dec. 3 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. today announced the issuance of three U.S. patents covering core chemical...

Nov 17, 2003, 00:00 ET

Families of Spinal Muscular Atrophy and Paratek Pharmaceuticals Announce Partnership to Find a Treatment or Spinal Muscular Atrophy

BOSTON and LIBERTYVILLE, Ill, Nov. 17 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. and Families of Spinal Muscular Atrophy (FSMA), an...

Oct 29, 2003, 00:00 ET

Paratek Appoints Vice President of Manufacturing and Executive Director for Clinical Research

BOSTON, Oct. 29 /PRNewswire/ -- Paratek Pharmaceuticals, Inc., a private Boston-based pharmaceuticals company engaged in the development of new...

Sep 15, 2003, 01:00 ET

Bayer and Paratek Pharmaceuticals Sign Collaboration Agreement For the Novel Antibiotic BAY 73-6944/PTK 0796

LEVERKUSEN, Germany and BOSTON, Sept. 15 /PRNewswire/ -- Bayer AG, Bayer Pharmaceuticals Corp., USA and Paratek Pharmaceuticals, Inc., USA have...

May 19, 2003, 01:00 ET

Paratek to Present at the 103rd General Meeting of the American Society for Microbiology

WASHINGTON and BOSTON, May 19 /PRNewswire/ -- Paratek Pharmaceuticals, Inc., a private Boston-based pharmaceuticals company engaged in the...

Feb 12, 2003, 00:00 ET

Paratek Announces Addition to Management Team

BOSTON, Feb. 12 /PRNewswire/ -- Paratek Pharmaceuticals, Inc., a private Boston-based pharmaceuticals company engaged in the development of new...

Oct 29, 2002, 00:00 ET

Paratek Pharmaceuticals to Discuss Lead Candidate Tetracycline at MassOpps 4th Annual Investor Conference

BOSTON, Oct. 29 /PRNewswire/ -- Paratek Pharmaceuticals, Inc., a private Boston-based pharmaceuticals company engaged in the development of new...

Oct 03, 2002, 01:00 ET

Paratek Pharmaceuticals to Present at UBS Warburg Conference; Presentation Details Recent Milestones and Clinical Trial Plans

NEW YORK, Oct. 3 /PRNewswire/ -- Paratek Pharmaceuticals, Inc., a private Boston-based pharmaceuticals company that is engaged in the development...

Sep 03, 2002, 01:00 ET

Paratek Pharmaceuticals Awarded NIH Grant to Search for Novel Anti-Malarial Tetracyclines

BOSTON, Sept. 3 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced today that it received a Phase I Small Business Innovative Research grant...

Aug 12, 2002, 01:00 ET

Paratek Hires Director of Regulatory Affairs; Company Gearing up for Clinical Trials by Year's End

BOSTON, Aug. 12 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. today announced the appointment of Donna Supko, Ph.D. as Director of Regulatory...

Jul 23, 2002, 01:00 ET

Paratek Issued U.S. Patent Covering Second Genetic Target In Fight Against Microbial Multiple-Drug Resistance

BOSTON, July 23 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. today announced the issuance of U.S. Patent No. 6,346,391, entitled "Methods of...

Jun 10, 2002, 01:00 ET

Paratek Pharmaceuticals Chairman and Co-Founder Dr. Walter Gilbert Receives Heritage Award at BIO 2002

TORONTO, June 10 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced today that its chairman and co-founder Dr. Walter Gilbert, the renowned...

Jun 07, 2002, 01:00 ET

Paratek Pharmaceuticals to Present at BIO 2002 Business Forum

TORONTO, June 7 /PRNewswire/ -- Paratek Pharmaceuticals, Inc., a private biopharmaceuticals company engaged in the discovery and...

May 28, 2002, 01:00 ET

Paratek Pharmaceuticals Completes Final Closing of $30.4 Million Financing

BOSTON, May 28 /PRNewswire/ -- Paratek Pharmaceuticals, Inc., a privately held company developing products to treat infectious diseases with a...

Apr 09, 2002, 01:00 ET

Paratek Pharmaceuticals Appoints AOL Time Warner Vice Chairman Kenneth J. Novack to Board of Directors

BOSTON, April 9 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced today the addition of Kenneth J. Novack to its Board of Directors. Mr....

Dec 17, 2001, 00:00 ET

Paratek Pharmaceuticals Presents Anti-Malarial Advances with Novel Tetracyclines at ICAAC 2001

CHICAGO, Dec. 17 /PRNewswire/ -- Today, Paratek Pharmaceuticals, Inc. researcher Dr. Michael Draper will give a presentation at the 41st Annual...